By Professor Michael Proinsias Farrell

Journal articles

Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L, 2023, 'Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review', The Lancet Global Health, 11, pp. e673 - e683, http://dx.doi.org/10.1016/S2214-109X(23)00058-X

Saxby K; Ireland A; Ghijben P; Sweeney R; Sia KL; Chen E; Farrell M; McRobbie H; Courtney R; Petrie D, 2023, 'Household Composition and Smoking Behavior in a Prospective Longitudinal Australian Cohort', Nicotine and Tobacco Research, 25, pp. 859 - 866, http://dx.doi.org/10.1093/ntr/ntac270

Colledge-Frisby S; Jones N; Degenhardt L; Hickman M; Padmanathan P; Santo T; Farrell M; Gisev N, 2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998

McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O’Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ, 2023, 'A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland', Familial Cancer, 22, pp. 135 - 149, http://dx.doi.org/10.1007/s10689-022-00313-0

Yuen WS; Peacock A; Man N; Callinan S; Slade T; Farrell M; Mattick R; Livingston M; Peacock A, 2023, 'Age, period and cohort effects on alcohol-related risky behaviours in Australia from 2001 to 2016', Addiction, 118, pp. 438 - 448, http://dx.doi.org/10.1111/add.16061

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of cocaine-related completed suicide in Australia, 2000–2021', Drug and Alcohol Dependence, 244, http://dx.doi.org/10.1016/j.drugalcdep.2023.109803

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, 42, pp. 582 - 591, http://dx.doi.org/10.1111/dar.13581

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959

Black E; Mammen K; Deacon RM; Ezard N; Mills L; Dunlop AJ; Montebello M; Reid D; Childs S; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Holmes J; Lintzeris N, 2023, 'Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019', Drug and Alcohol Review, 42, pp. 389 - 400, http://dx.doi.org/10.1111/dar.13588

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, 118, pp. 297 - 306, http://dx.doi.org/10.1111/add.16055

Darke S; Zahra E; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000–2021', Clinical Toxicology, 61, pp. 260 - 265, http://dx.doi.org/10.1080/15563650.2023.2184243

Howard BC; McRobbie H; Petrie D; Barker D; Mendelsohn C; Anderson J; Borland R; Naughton F; Tutka P; Zwar N; Boland VC; Aiken A; Shakeshaft A; Gartner C; Richmond RL; Hall W; Mattick RP; Farrell M; Courtney RJ, 2022, 'Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06644-8

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial', Drug and Alcohol Dependence, 241, pp. 109692, http://dx.doi.org/10.1016/j.drugalcdep.2022.109692

Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529

Farrell M, 2022, 'From harm to hope or is it from harmful to hopeless?', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103845

Acheson LS; Ezard N; Lintzeris N; Dunlop A; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', PLoS ONE, 17, pp. e0275371, http://dx.doi.org/10.1371/journal.pone.0275371

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, pp. 103788, http://dx.doi.org/10.1016/j.drugpo.2022.103788

Dewald EL; Clark DS; Casey DT; Khan SF; Mariscal D; Nicola PD; MacGowan BJ; Hartouni EP; Rubery MS; Choate C; Nikroo A; Smalyuk VA; Landen OL; Ratledge M; Fitzsimmons P; Farrell M; Mauldin M; Rice N, 2022, 'Compensating cylindrical Hohlraum mode 4 asymmetry via capsule thickness tailoring and effects on implosions', Physics of Plasmas, 29, http://dx.doi.org/10.1063/5.0100095

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548

McKenna MC; McGovern E; Farrell M; Killeen RP; McGuigan C; Connolly S, 2022, 'Neurogenic muscle hypertrophy following L5 motor radiculopathy', PRACTICAL NEUROLOGY, http://dx.doi.org/10.1136/pn-2022-003461

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Farrell M; Hickman M; Webster D; Hayward A; Degenhardt L, 2022, 'Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia', PLoS Medicine, 19, pp. e1004049, http://dx.doi.org/10.1371/journal.pmed.1004049

Colledge-Frisby S; Jones N; Larney S; Peacock A; Lewer D; Brothers TD; Hickman M; Farrell M; Degenhardt L, 2022, 'The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109494

Hall W; Farrell M, 2022, 'Aldous Huxley's The Doors of Perception', Addiction, 117, pp. 1811 - 1815, http://dx.doi.org/10.1111/add.15713

Nielsen S; Picco L; Murnion B; Winters B; Matheson J; Graham M; Campbell G; Parvaresh L; Khor KE; Betz-Stablein B; Farrell M; Lintzeris N; Le Foll B, 2022, 'Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies', Neuropsychopharmacology, 47, pp. 1315 - 1330, http://dx.doi.org/10.1038/s41386-022-01322-4

Klaas KM; Fischer PR; Segner S; Tsai Owens M; Fahrenkamp A; Geske J; Hofschulte D; Farrell M; Harbeck-Weber C; Biggs BK, 2022, 'Excessive Postural Tachycardia and Postural Orthostatic Tachycardia Syndrome in Youth: Associations With Distress, Impairment, Health Behaviors, and Medication Recommendations', JOURNAL OF CHILD NEUROLOGY, 37, pp. 599 - 608, http://dx.doi.org/10.1177/08830738221078410

Zahra E; Chen R; Nielsen S; Tran AD; Santo T; Degenhardt L; Farrell M; Byrne J; Ali R; Larance B, 2022, 'Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients', Drug and Alcohol Review, 41, pp. 841 - 850, http://dx.doi.org/10.1111/dar.13437

Chaillon A; Bharat C; Stone J; Jones N; Degenhardt L; Larney S; Farrell M; Vickerman P; Hickman M; Martin NK; Bórquez A, 2022, 'Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia', Addiction, 117, pp. 1338 - 1352, http://dx.doi.org/10.1111/add.15736

Krausz M; Westenberg JN; Tsang V; Suen J; Ignaszewski MJ; Mathew N; Azar P; Cabanis M; Elsner J; Vogel M; Spijkerman R; Orsolini L; Vo D; Moore E; Moe J; Strasser J; Köck P; Marian C; Dürsteler KM; Backmund M; Röhrig J; Post M; Haltmayer H; Wladika W; Trabi T; Muller C; Rechberger G; Teesson M; Farrell M; Christie G; Merry S; Mamdouh M; Alinksy R; Levy S; Fishman M; Rosenthal R; Jang K; Choi F, 2022, 'Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth', Medicina (Lithuania), 58, http://dx.doi.org/10.3390/medicina58040539

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310

Ji YD; McKinley SK; Farrell M; Hemingway M; Qadan M; Saillant N; Phitayakorn R, 2022, 'Operating Room Staff Perceptions of Medical Students', JOURNAL OF SURGICAL EDUCATION, 79, pp. 370 - 382, http://dx.doi.org/10.1016/j.jsurg.2021.10.011

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Weatherburn D; Darke S; Zahra E; Farrell M, 2022, 'Who would try (or use more) cannabis if it were legal?', Drug and Alcohol Review, 41, pp. 386 - 395, http://dx.doi.org/10.1111/dar.13360

Bosworth RJ; Borschmann R; Altice FL; Kinner SA; Dolan K; Farrell M, 2022, 'HIV/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review', International Journal of Prisoner Health, 18, pp. 66 - 82, http://dx.doi.org/10.1108/IJPH-02-2021-0018

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Mammen K; Mills L; Deacon RM; Bruno R; Dunlop A; Holmes J; Luksza J; Shakeshaft A; Farrell M; Lintzeris N, 2022, 'Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions', Drug and Alcohol Review, 41, pp. 106 - 113, http://dx.doi.org/10.1111/dar.13346

Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103472

Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials', Drug and Alcohol Review, 42, http://dx.doi.org/10.1111/dar.13511

Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, 98, pp. 103396, http://dx.doi.org/10.1016/j.drugpo.2021.103396

Yuen WS; Bruno R; Chan GCK; McCambridge J; Slade T; Clare PJ; Aiken A; Kypri K; Hutchinson D; McBride N; Boland V; Upton E; Farrell M; Mattick RP; Peacock A; Peacock A, 2021, 'The experience of physiological and psychosocial alcohol-related harms across adolescence and its association with alcohol use disorder in early adulthood: A prospective cohort study', Alcoholism: Clinical and Experimental Research, 45, pp. 2518 - 2527, http://dx.doi.org/10.1111/acer.14726

Chrzanowska A; Man N; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths, Australia, 2012–2016: Drug pattern profile and demographic characteristics', Drug and Alcohol Dependence, 229, http://dx.doi.org/10.1016/j.drugalcdep.2021.109112

Courtney RJ; Tutka P; Farrell M, 2021, 'The Effect of Cytisine vs Varenicline on Smoking Cessation - Reply', JAMA - Journal of the American Medical Association, 326, pp. 1872 - 1873, http://dx.doi.org/10.1001/jama.2021.16064

Quinn B; Ward B; Agius PA; Jenkinson R; Hickman M; Sutton K; Hall C; McKetin R; Farrell M; Cossar R; Dietze PM, 2021, 'A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence', Drug and Alcohol Review, 40, pp. 1239 - 1248, http://dx.doi.org/10.1111/dar.13194

Farrell M; Griffiths K; Acheson L; Bruno R, 2021, 'APSAD 2021 Conference, 7-10 November 2021, Virtual', Drug and alcohol review, 40, pp. S4 - S154, http://dx.doi.org/10.1111/dar.13384

McKetin R; Sutherland R; Peacock A; Farrell M; Degenhardt L, 2021, 'Patterns of smoking and injecting methamphetamine and their association with health and social outcomes', Drug and Alcohol Review, 40, pp. 1256 - 1265, http://dx.doi.org/10.1111/dar.13364

Farrell MP, 2021, 'The Faces in Einstein's Looking-Glass Self', CONTEMPORARY SOCIOLOGY-A JOURNAL OF REVIEWS, 50, pp. 470 - 472, http://dx.doi.org/10.1177/00943061211050045d

Bharat C; Degenhardt L; Dobbins T; Larney S; Farrell M; Barbieri S, 2021, 'Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109091

Back to profile page